Glenview Trust co Sells 1,047 Shares of MetLife, Inc. (NYSE:MET)

Glenview Trust co trimmed its holdings in shares of MetLife, Inc. (NYSE:MET) by 2.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,192 shares of the financial services provider’s stock after selling 1,047 shares during the quarter. Glenview Trust co’s holdings in MetLife were worth $3,127,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in MET. CX Institutional raised its holdings in MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after purchasing an additional 9,337 shares during the period. Bank of New York Mellon Corp raised its stake in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after buying an additional 4,606,748 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of MetLife by 27.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after acquiring an additional 2,940 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in MetLife by 1.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock worth $63,559,000 after acquiring an additional 12,723 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in MetLife during the 3rd quarter worth approximately $2,960,000. 94.99% of the stock is currently owned by institutional investors.

MetLife Price Performance

MET stock opened at $80.62 on Monday. The company has a fifty day simple moving average of $83.44 and a two-hundred day simple moving average of $82.50. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $54.92 billion, a P/E ratio of 13.50, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th were issued a dividend of $0.545 per share. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.70%. MetLife’s payout ratio is presently 36.52%.

Analyst Upgrades and Downgrades

MET has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods dropped their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research report on Wednesday, February 12th. Morgan Stanley increased their price target on MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research note on Friday, February 28th. Barclays dropped their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. BMO Capital Markets began coverage on MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 target price on the stock. Finally, TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, MetLife currently has an average rating of “Moderate Buy” and a consensus price target of $94.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.